Study to Evaluate the Efficacy and Safety of FOLFOX-4 Plus Cetuximab Versus UFOX Plus Cetuximab.

Clinical trial NCT00439517 · COMPLETED

Trial details

NCT number: NCT00439517
Sponsor: Merck KGaA, Darmstadt, Germany
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Previously Untreated Metastatic Colorectal Cancer

Start date: 2007-02-01
Primary completion: 2009-06-01
Enrollment: 302

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.